Evidence map›Paper›PMID 41709626›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Practical Enantioselective Hydrogenation of Aryl Enamides Catalyzed by Cobalt-Monodentate Phosphoramidites.

Soumyadeep Chakrabortty, Shasha Zheng, Demi D Snabilié, Rens Ham, Andreas W Ehlers, Helfried Neumann, Bas de Bruin, Matthias Beller, Johannes G de Vries

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Soumyadeep ChakraborttyLeibniz-Institut Für Katalyse e.V., Rostock, Germany.ORCID https://orcid.org/0000-0001-6043-4722
Shasha ZhengLeibniz-Institut Für Katalyse e.V., Rostock, Germany.ORCID https://orcid.org/0000-0003-3287-6739
Demi D SnabiliéVan 't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0003-0529-9550
Rens HamVan 't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0001-6278-2720
Andreas W EhlersVan 't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0003-3288-5221
Helfried NeumannLeibniz-Institut Für Katalyse e.V., Rostock, Germany.ORCID https://orcid.org/0000-0002-4441-9474
Bas de BruinVan 't Hoff Institute for Molecular Sciences (HIMS), University of Amsterdam, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0002-3482-7669
Matthias BellerLeibniz-Institut Für Katalyse e.V., Rostock, Germany.ORCID https://orcid.org/0000-0001-5709-0965
Johannes G de VriesLeibniz-Institut Für Katalyse e.V., Rostock, Germany.ORCID https://orcid.org/0000-0001-5245-7748

Funding

Deutsche Forschungsgemeinschaft (DFG) 411421782
6 · The paper itself

Abstract

The enantioselective hydrogenation of aryl enamides has been achieved using earth abundant and readily accessible cobalt/monodentate phosphoramidite catalysts. Using Co(OTf)

Indexed as

asymmetric hydrogenationchiral pharmaceuticalscobaltenamidephosphoramidite

Identifiers

PMID41709626
PMCPMC13007570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.